2016
DOI: 10.1007/s00216-016-9880-6
|View full text |Cite
|
Sign up to set email alerts
|

Glycans and glycoproteins as specific biomarkers for cancer

Abstract: Protein glycosylation and other post-translational modifications are involved in potentially all aspects of human growth and development. Defective glycosylation has adverse effects on human physiological conditions and accompanies many chronic and infectious diseases. Altered glycosylation can occur at the onset and/or during tumor progression. Identifying these changes at early disease stages may aid in making decisions regarding treatments as early intervention can greatly enhance survival. This review high… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
228
0
2

Year Published

2017
2017
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 292 publications
(243 citation statements)
references
References 143 publications
0
228
0
2
Order By: Relevance
“…For example, glycosylation affects the safety and efficacy of biological therapeutics and serves as a biomarker of disease. [35] The N-glycans that are associated with dysfunction arise from alterations of a predictable base structure that contains a mannose core attached to N-acetylglucosamine linked to galactose [6]. In glycoproteins found in animals, galactose residues are generally linked to an N -acetylglucosamine residue through a β(1-4) linkage, (Galβ(1-4)GlcNAc).…”
Section: Introductionmentioning
confidence: 99%
“…For example, glycosylation affects the safety and efficacy of biological therapeutics and serves as a biomarker of disease. [35] The N-glycans that are associated with dysfunction arise from alterations of a predictable base structure that contains a mannose core attached to N-acetylglucosamine linked to galactose [6]. In glycoproteins found in animals, galactose residues are generally linked to an N -acetylglucosamine residue through a β(1-4) linkage, (Galβ(1-4)GlcNAc).…”
Section: Introductionmentioning
confidence: 99%
“…[10] Sialylated glycans and glycoproteins have attracted special attention based on observations that they are upregulated in numerous cancers and, in circulation, have the potential to serve as biomarkers of disease. [11] …”
mentioning
confidence: 99%
“…At present, glycans have been used as candidate diagnostic markers and therapeutic targets in clinics (19,20). The modulation of N-Glycan biosynthesis (P value = 6.24e-14, ranked twelfth) changed the glycosylation of proteins and/or lipids, which made the functions and structures of glycoproteins and/or glycolipids change.…”
Section: Discussionmentioning
confidence: 99%